Budget impact analysis of insulin glargine vs. isophane protamine insulin treatment for patients with type-2 diabetes and severe hypoglycemia in Thailand
ObjectiveThis study aimed to assess the financial impact of different adoption rates of insulin glargine (IGlar) treatment compared to isophane protamine (neutral protamine hagedorn [NPH]) insulin treatment for patients with type-2 diabetes (T2D) and severe hypoglycemia in Thailand from the payer’s...
Saved in:
Main Authors: | Unchalee Permsuwan, Chaicharn Deerochanawong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1415908/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiological and pathophysiological actions of insulin in the liver
by: Naoto Kubota, et al.
Published: (2025-02-01) -
Association Between Four Non-Insulin-Based Insulin Resistance Indices and the Risk of Post-Stroke Depression
by: Wang P, et al.
Published: (2025-01-01) -
Level of Satisfaction Among Patients Using Insulin Administered by Pen vs Vial/Syringe. An Observational Prospective Study
by: Valladales-Restrepo LF, et al.
Published: (2025-01-01) -
Shiftwork and insulin resistance in professional drivers: exploring the association using non-insulin-based surrogate measures
by: Mirella Youssef Tawfik, et al.
Published: (2025-01-01) -
Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
by: Ilhan Satman, et al.
Published: (2013-08-01)